← FDA Drug Approvals (Drugs@FDA)
VEOZAH
NDA · New Drug Application · Sponsor: ASTELLAS · Approved 2023-05-12
Drug application
- FDA Application #
NDA216578- Application type
- New Drug Application
- Brand name
- VEOZAH
- Generic name
- FEZOLINETANT
- Active ingredients
- FEZOLINETANT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ASTELLAS
- Manufacturer
- Astellas Pharma US, Inc.
- First approval
- 2023-05-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown